Related Experiment Video
Updated: Jun 23, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
Proteomic Profiling of Hypoplastic Lungs Suggests an Underlying Inflammatory Response in the Pathogenesis of Abnormal
Richard Wagner1,2,3,4, Paula Lieckfeldt1,2,3,4, Hadeesha Piyadasa3,5,6
1Departments of Surgery, Division of Pediatric Surgery, Pediatrics & Child Health, University of Manitoba, Winnipeg, MB, Canada.
Insights
Congenital diaphragmatic hernia (CDH) causes abnormal lung development. This study found inflammatory pathways, particularly STAT3 signaling, are key to lung hypoplasia in CDH, offering new therapeutic targets.
Area of Science:
- Developmental Biology
- Proteomics
- Neonatal Pathology
Background:
- Congenital diaphragmatic hernia (CDH) is a severe birth defect characterized by abnormal lung development and high mortality.
- The precise mechanisms driving lung hypoplasia in CDH remain poorly understood, hindering effective treatment strategies.
Purpose of the Study:
- To investigate the proteomic differences in fetal lungs affected by CDH compared to controls.
- To identify key molecular pathways and proteins involved in the pathogenesis of CDH-induced lung hypoplasia.
- To explore potential therapeutic targets for improving lung development in CDH.
Main Methods:
- Comparative proteomic analysis of fetal rat lungs exposed to nitrofen (CDH model) versus vehicle controls.
- Pathway analysis to identify enriched biological processes in CDH lungs.
- Immunohistochemical analysis of Tenascin C and STAT3 expression in rat and human CDH lungs.
- Ex vivo experiments using fetal rat lung explants to assess the effect of STAT3 inhibition.
- Analysis of cytokine levels in fetal tracheal aspirates from CDH patients.
Main Results:
- Proteomic analysis revealed significant enrichment of inflammatory response proteins, including cytokine signaling and Epstein Barr Virus pathways, in nitrofen-induced CDH lungs.
- Tenascin C was decreased, while STAT3 was significantly increased in the airway epithelium of CDH lungs.
- STAT3 inhibition partially rescued the lung hypoplasia phenotype ex vivo, promoting peripheral lung budding.
- Elevated levels of STAT3-associated cytokines (IL-15, IL-9, IL-2) were observed in CDH survivors' tracheal aspirates.
Conclusions:
- Downstream inflammatory processes, driven by STAT3 signaling, are critically involved in the pathogenesis of abnormal lung development in CDH.
- Targeting STAT3 signaling presents a potential therapeutic strategy to improve lung development in CDH patients.
- This study provides novel insights into the molecular mechanisms underlying CDH lung hypoplasia using an unbiased proteomics approach.
Abstract:
The pathogenesis of lung hypoplasia in congenital diaphragmatic hernia (CDH), a common birth defect, is poorly understood. The diaphragmatic defect can be repaired surgically, but the abnormal lung development contributes to a high mortality in these patients. To understand the underlying pathobiology, we compared the proteomic profiles of fetal rat lungs at the alveolar stage (E21) that were either exposed to nitrofen in utero (CDH lungs, n=5) or exposed to vehicle only (non-CDH control lungs, n=5). Pathway analysis of proteomic datasets showed significant enrichment in inflammatory response proteins associated with cytokine signaling and Epstein Barr Virus in nitrofen CDH lungs. Among the 218 significantly altered proteins between CDH and non-CDH control lungs were Tenascin C, CREBBP, LYN, and STAT3. We showed that Tenascin C was decreased around the distal airway branches in nitrofen rat lungs and human CDH lungs, obtained from stillborn fetuses that did not receive pre- or postnatal treatment. In contrast, STAT3 was significantly increased in the airway epithelium of nitrofen lungs at E21. STAT3 inhibition after direct nitrofen exposure to fetal rat lung explants (E14.5) partially rescued the hypoplastic lung phenotype ex vivo by increasing peripheral lung budding. Moreover, we demonstrated that several STAT3-associated cytokines (IL-15, IL-9, andIL-2) are increased in fetal tracheal aspirates of CDH survivors compared with nonsurvivors after fetoscopic endoluminal tracheal occlusion. With our unbiased proteomics approach, we showed for the first time that downstream inflammatory processes are likely involved in the pathogenesis of abnormal lung development in CDH.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pneumothorax II: Pathophysiology
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

